ANTERIS TECHNOLOGIES LTD 
By Rule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ALLIED HEALTHCARE GROUP LIMITED
ABN 35 088 221 078
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Christopher James Catlow |
Date of last notice | 29 January 2013 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Direct or indirect interest | Indirect |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Director related entities:
Broadscope Pty Ltd
A/C> Pty Ltd
|
Date of change | (a) 24 October 2013 |
No. of securities held prior to change | (a) 14,635,477 (b) 16,000,000 |
Class | (a) Ordinary Shares (b) Unlisted Options $0.06 exp 10/07/2016 |
Number acquired | (a) 2,927,095 (b) nil |
Number disposed | (a) nil (b) nil |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Issue price $0.05 per cent. Total consideration $146,354.75 |
No. of securities held after change | (a) 17,562,572 (b) 16,000,000 |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director's Interest NoticeNature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Shares issued under Rights Issue.
Part 2 - Change of director's interests in contractsNote: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
Interest after change | N/A |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? | N/A |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Appendix 3Y Change of Director's Interest Notice Appendix 3Y Change of Director's Interest NoticeRule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ALLIED HEALTHCARE GROUP LIMITED
ABN 35 088 221 078
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | William Graeme Rowley |
Date of last notice | 7 December 2012 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Direct or indirect interest | Direct |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | N/A |
Date of change | (a) 24 October 2013 |
No. of securities held prior to change | (a) 16,584,292 (b) 8,000,000 |
Class | (a) Ordinary Shares (b) Unlisted Options $0.06 exp 10/07/2016 |
Number acquired | (a) 3,316,858 (b) nil |
Number disposed | (a) nil (b) nil |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Issue price $0.05 per cent. Total consideration $165,842.90 |
No. of securities held after change | (a) 19,901,150 (b) 8,000,000 |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Appendix 3Y Change of Director's Interest NoticeNature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Shares issued under Rights Issue.
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
Interest after change | N/A |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? | N/A |
+ See chapter 19 for defined terms.
Appendix 3Y Page 4 01/01/2011
Appendix 3Y Change of Director's Interest Notice Appendix 3Y Change of Director's Interest NoticeRule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ALLIED HEALTHCARE GROUP LIMITED
ABN 35 088 221 078
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Lee Eric Rodne |
Date of last notice | 29 January 2013 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Direct or indirect interest | Direct |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | N/A |
Date of change | (a) 24 October 2013 |
No. of securities held prior to change | (a) 24,128,534 (b) 19,200,000 |
Class | (a) Ordinary Shares (b) Unlisted Options $0.06 exp 10/07/2016 |
Number acquired | (a) 2,000,000 (b) nil |
Number disposed | (a) nil (b) nil |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Issue price $0.05 per cent. Total consideration $100,000.00 |
No. of securities held after change | (a) 26,128,534 (b) 19,200,000 |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 5
Appendix 3Y Change of Director's Interest NoticeNature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Shares issued under Rights Issue.
Part 2 - Change of director's interests in contractsNote: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
Interest after change | N/A |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? | N/A |
+ See chapter 19 for defined terms.
Appendix 3Y Page 6 01/01/2011
Appendix 3Y Change of Director's Interest Notice Appendix 3Y Change of Director's Interest NoticeRule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ALLIED HEALTHCARE GROUP LIMITED
ABN 35 088 221 078
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Peter Turvey |
Date of last notice | 27 September 2013 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition o f "notifiable interest of a director" should be
disclosed in this part.
Direct or indirect interest | Direct |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | N/A |
Date of change | (a) 24 October 2013 |
No. of securities held prior to change | (a) 1,721,997 (b) 666,667 |
Class | (a) Ordinary Shares (b) Unlisted Options $0.06 exp 18/05/2017 |
Number acquired | (a) 344,399 (b) nil |
Number disposed | (a) nil (b) nil |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Issue price $0.05 per cent. Total consideration $17,219.95 |
No. of securities held after change | (a) 2,066,396 (b) 1,000,000 |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 7
Appendix 3Y Change of Director's Interest NoticeNature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Shares issued under Rights Issue.
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
Interest after change | N/A |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? | N/A |
+ See chapter 19 for defined terms.
Appendix 3Y Page 8 01/01/2011
Appendix 3Y Change of Director's Interest Notice Appendix 3Y Change of Director's Interest NoticeRule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ALLIED HEALTHCARE GROUP LIMITED
ABN 35 088 221 078
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Michael Charles Bennett |
Date of last notice | 29 January 2013 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Direct and Indirect |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Director related entities: Parerg Pty Ltd
Parhel Pty Ltd |
Date of change | (a) 24 October 2013 |
No. of securities held prior to change | (a) 9,970,000 (b) 2,500,000 |
Class | (a) Ordinary Shares (b) Unlisted Options $0.06 exp 10/07/2016 |
Number acquired | (a) 1,474,000 (b) nil |
Number disposed | (a) nil (b) nil |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Issue price $0.05 per cent. Total consideration 73,700.00 |
No. of securities held after change | (a)11,444,000 (b) 2,500,000 |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 9
Appendix 3Y Change of Director's Interest NoticeNature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Shares issued under Rights Issue.
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
Interest after change | N/A |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? | N/A |
+ See chapter 19 for defined terms.
Appendix 3Y Page 10 01/01/2011
|
distributed by
|
